The study aims to investigate homeostatic and hedonic mechanisms regulating appetite, energy balance and metabolism in obesity and the effects of three distinct obesity treatments on these regulatory mechanisms.
Obesity is widely acknowledged health problem affecting millions of people globally. Enormous efforts have been made to solve the problem, but long-term results of the conventional weight loss and/or weight management strategies have been poor indicating still inadequate understanding of the problem. Surgical, rather than weight-centred lifestyle interventions, have proved to be the most effective tool available to treat obesity within individuals suitable for obesity surgery. Current surgical interventions are, however, suitable only for a small subset of obese individuals. In general, there is a need for development of new approaches and therapies that are safer and more individualized to each patient in the struggle against obesity and related disorders. To achieve these goals, research must focus to investigate and understand the complex homeostatic and hedonic regulation of eating behavior and energy balance in different physiological and pathological conditions. This study aims to investigate homeostatic and hedonic mechanisms regulating energy balance and metabolism in obesity and the effects of three distinct obesity treatments on these regulatory mechanisms. The regulatory mechanisms are investigated at the level of metabolism, autonomic and central nervous systems as well as subjective, both implicit and explicit, experiences. A total of 90 obese female volunteers (18-65 years, body mass index \> 35 kg/m2), of which 30 females waiting for bariatric surgery (SURG), 30 females attending a dietary treatment program for obesity (DIET) and 30 females attending Health at Every Size (HAES) program, will participate in the study. The obesity treatment for SURG and DIET groups follows the principles of the Current Care Guidelines for Obesity (adults) and the treatment for the HAES group applies the strategies of the non-diet wellness-based HAES program. The treatment programs of the DIET and HAES groups include 8-10 weekly group sessions organized by authorised nutritionist. The study includes also two four-hour visits at the research laboratory of the Institute of Public Health and Clinical Nutrition, University of Eastern Finland, the first visit organized before the participants attend any of the obesity treatments and the second visit 12 months later. During the laboratory visits psychophysiological signals (EEG, ANS, facial EMG and eye tracking) are monitored and blood samples taken throughout the experimental period. Participants will also perform two computer-based test sessions, the first one at baseline and the second before a snack meal. Two meals (breakfast and snack meal) are offered to the participants during the experiment in order to study the regulatory mechanisms of interest both at the homeostatic and hedonic states.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
50
bariatric surgery according to Finnish Current Care Guidelines for Obesity in adults
dietary weight loss program according to Finnish Current Care Guidelines for Obesity in adults
treatment is based on the previously published procedure (e.g. Bacon et al. 2002) and Health At Every Size trademark, consisting of body acceptance, eating behaviour, physical activity, nutrition, and social support
Implicit associations
D-score of Implicit Association Test
Time frame: Change from baseline D-score at 1 year
Explicit ratings
Ratings on visual analogue scales for wanting and liking of presented foods
Time frame: Change from baseline visual analogue scale at 1 year
Event-related potentials
Event-related potentials measured by EEG
Time frame: Change from baseline event-related potentials at 1 year
Glucose
Plasma glucose, fasting, postprandial
Time frame: Change from baseline glucose at 1 year
Insulin
plasma insulin, fasting, postprandial
Time frame: Change from baseline insulin at 1 year
Ghrelin
plasma ghrelin, fasting, postprandial
Time frame: Change from baseline ghrelin at 1 year
Leptin
serum leptin, fasting
Time frame: Change from baseline leptin at 1 year
Peptide YY
plasma peptide YY, fasting, postprandial
Time frame: Change from baseline PYY at 1 year
Endocannabinoids
plasma endocannabinoids, fasting, postprandial
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: Change from baseline endocannabinoids at 1 year
Weight
body weight, fasting
Time frame: Change from baseline weight at 1 year
Eating behaviour
self-reported questionnaires
Time frame: Change from baseline eating behaviour at 1 year
Psychosocial characteristics
self-reported questionnaires
Time frame: Change from baseline psychosocial characteristics at 1 year